Hone Health Testosterone Cypionate (TRT)vsMaximus Enclomiphene Protocol

Testosterone cypionate is an esterified form of testosterone injected into muscle or subcutaneous fat, where it slowly releases into the bloodstream over days. It directly replaces the hormone your body isn't making enough of, restoring serum testosterone into a therapeutic range. Because the brain senses adequate testosterone, it dials down its own LH/FSH signal — which is why TRT suppresses natural production and sperm output.

Enclomiphene is the trans-isomer of clomiphene. It occupies estrogen receptors in the hypothalamus so the brain 'thinks' estrogen is low, which ramps up GnRH and downstream pituitary LH and FSH. That hormonal push tells the testes to make more testosterone naturally — which is why, unlike injected testosterone, it tends to maintain (rather than suppress) sperm production.

Injectable testosterone is FDA-approved and the most established TRT modality. Endocrine Society guidelines support testosterone therapy for men with consistent symptoms and unequivocally low morning testosterone, with documented improvements in libido, energy, mood, and lean mass. Efficacy at relieving hypogonadal symptoms is well established; treatment requires monitoring because it suppresses fertility and can raise red blood cell counts.

Randomized Phase II trials found enclomiphene restored morning total testosterone to levels comparable to topical testosterone gel in men with secondary hypogonadism, while raising LH/FSH and preserving sperm counts. A 2025 systematic review and meta-analysis of SERM therapy reported a mean total-testosterone increase of roughly 274 ng/dL versus placebo. Evidence is solid for short-to-medium-term T restoration; long-term outcome data remain limited.

Common effects include injection-site soreness and acne. Important risks that require monitoring include elevated red blood cell count (polycythemia), suppressed sperm production and potential infertility, testicular shrinkage, and the need for prostate and cardiovascular oversight. This is educational information and not a substitute for medical advice.

In clinical studies side effects were generally infrequent and mild — headache, nausea, hot flashes, dizziness, or GI upset. Rarer concerns include mood changes and visual disturbances (a known SERM class effect); any vision change warrants stopping and contacting your clinician. This is educational information, not medical advice.

As of 2026, the cypionate medication starts near $28/month depending on dose and frequency, but that's separate from a required physician membership — $135/month (Plus, 8-11 biomarkers) or $155/month (Premium, 40+ biomarkers). The initial diagnostic panel is discounted to roughly $45-$65. The injectable drug may be insurance-covered at a pharmacy, but the membership and program services generally are not.

As of 2026, the enclomiphene-only plan is advertised from $99.99/month on a committed annual plan and $199.99/month month-to-month. Required testosterone lab panels in the first two months run $99.99 each and are billed separately, so realistically budget for medication plus labs in your early months. Compounded medication is generally not insurance-reimbursable.

Adult men with symptoms of low testosterone confirmed by morning blood tests showing low levels. Not appropriate for men with untreated prostate or breast cancer, uncontrolled polycythemia, or those actively trying to conceive. A physician reviews labs and history before prescribing.

Adult men with lab-documented low testosterone and intact testicular function (secondary hypogonadism). You must complete bloodwork and a clinician review; men seeking fertility preservation are common candidates. Not appropriate for those with primary testicular failure, certain liver or eye conditions, or men who could be misusing it without monitoring.